- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04697212
Improving Communication and Healthcare Outcomes for Patients With Communication Disabilities
Improving Communication and Healthcare Outcomes for Patients With Communication Disabilities: The INTERACT Trial
In the United States, 14% of all adults report a speech, language, voice, and/or hearing disability (collectively known as communication disabilities, CD). Patients with CD, experience inequities in receipt of and access to high-quality healthcare services, including primary care. Poor patient-provider communication is a significant contributor to these disparities. When healthcare providers use evidence-based communication strategies, patients with CD have improved communication outcomes and satisfaction. Unfortunately, providers rarely use the strategies in practice. The objective of this study is to compare the effectiveness and implementation of two interventions to increase primary care providers' use of communication strategies, improving the quality of their communication with patients with CD.
Using a stepped-wedge study design and guided by the RE-AIM framework, we will compare a healthcare team-directed intervention (training) to a healthcare team-directed intervention + patient-directed intervention (patient-prompt list). In the healthcare team-directed intervention, the team will receive training on evidence-based communication strategies for patients with CD. In the patient-directed intervention, patients with CD will complete a "patient prompt" list that elicits strategies that they prefer the healthcare team to use during their visit.
The primary aim of the study is to compare the effectiveness of the interventions on patient-reported experience in primary care practices across 4 healthcare systems using a stepped-wedge randomized controlled trial.
Hypothesis 1: Patients with CD will report a higher quality of health, more positive experience, and greater self-efficacy when they use the patient-directed tool (intervention A+B) as compared to patients with CD in the healthcare team education-only phase (intervention A).
Hypothesis 2. Providers will use more patient-centered communication and strategies with the patient-directed intervention.
The second aim is to examine the adoption, implementation, and short-term sustainability of the interventions.
Study Overview
Status
Conditions
Detailed Description
About 40 million people have a communication disability (CD), which includes hearing, speech, language, and voice disabilities. Compared to non-disabled patients, patients with CD are more likely to have a greater number of chronic conditions, and have higher rates of asthma, hypertension, emphysema, cardiovascular disease, diabetes and arthritis. Approximately one third of people with CD report the quality of their health as fair/poor as compared to only 11% of patients without CD. Patients with CD are 2-4 times more likely to report difficulty finding a provider than those without CD. When they do access care, they report that the quality of care and communication they receive is low.
Communication strategies that patients with CD require may vary, and providers need to elicit and then adapt to patients' preferences for communication strategies. Provider education and patient-prompt tool interventions have demonstrated effectiveness in general populations. Provider communication education significantly improves their patient-centered communication. Patient-prompt tools empower patients to identify topics and communication styles they prefer and then share this information with their healthcare provider. While provider education and patient-prompt tools have been proven effective, their effectiveness has not been compared in the primary care setting for patients with CD. Therefore, the aim of this study is to adapt these two types of interventions for patients with CD in the primary care setting and then compare their effectiveness at improving patient-reported health related quality of life and experience with care.
In this study we will conduct a stepped-wedge randomized control trial design. The study will take place at 4 sites that have unique contributions that will add to the generalizability and dissemination of the results. They are diverse in their geographic location, include academic and community clinics, represent urban and suburban locations, and include racially and ethnically diverse patients. Eight clinics, 2 at each site, will be part of the trial.
All participating clinic sites will receive the healthcare team-directed intervention (intervention A) and then will be randomized as to when they begin implementing the patient-directed tool (intervention B). The A versus A+B study design ensures all participating healthcare team members receive the training, as national policies require healthcare team members receive training on effective communication with patients with CD. We will randomize at the clinic-level cluster to eliminate spillover intervention effects amongst providers within the same clinic.
Participating healthcare team members will all receive the healthcare team-directed intervention (a general overview training about communication disabilities and communication strategies that can be used with patients) during the month preceding trial roll-out. Clinics will be randomized as to when they begin implementing the patient-directed tool, with a new clinic beginning every two months. One month prior to implementation, the healthcare team members will receive a booster education training, be introduced to the patient-directed tool, and alerted that they will be handed the completed tool by patients with CD during the patients' clinical encounters.
To measure patient and provider perceptions, both groups will complete a survey after the clinical encounter. A subset of encounters will be videotaped, and content analysis will document providers' use of patient-centered strategies and any adaptations made to the intervention strategies. Chart review will document patients' healthcare utilization over time. To understand providers' experiences with both interventions and perceptions of feasibility, healthcare team members will participate in qualitative focus groups and interviews at 3 time points.
The outcomes from this study may help create patient and provider training and tools that, if proven successful, could be disseminated to other healthcare arenas to improve patient-provider communication and ultimately improved health outcomes for this vulnerable population.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Megan A Morris, PhD, MPH
- Phone Number: 303-724-3535
- Email: megan.a.morris@cuanschutz.edu
Study Contact Backup
- Name: Julie A Maertens, PhD
- Phone Number: 303-724-7319
- Email: julie.maertens@cuanschutz.edu
Study Locations
-
-
Colorado
-
Denver, Colorado, United States, 80205
- Not yet recruiting
- Denver Health
-
Contact:
- Megan A Morris, PhD, MPH
- Email: megan.a.morris@cuanschutz.edu
-
Lone Tree, Colorado, United States, 80124
- Not yet recruiting
- UCHealth Primary Care - Lone Tree
-
Contact:
- Megan A Morris, PhD, MPH
- Email: megan.a.morris@cuanschutz.edu
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Recruiting
- University of Illinois Chicago
-
Contact:
- Jenna Duffecy, PhD
- Email: jduffecy@uic.edu
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48104
- Not yet recruiting
- Michigan Medicine
-
Contact:
- Michael M McKee, MD, MPH
- Email: mmmckee@med.umich.edu
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Recruiting
- Mayo Clinic
-
Contact:
- Sean Phelan, PhD
- Email: phelan.sean@mayo.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient participants: Individuals with a communication disability who receive care at participating study sites
- Healthcare team participants: Healthcare staff and providers at participating study sites
Exclusion Criteria:
- Patient participants: Individuals without a communication disability
- Healthcare team participants: Individuals who do not work at participating study sites
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Healthcare team- + patient-directed intervention
Team education and patient tool
|
Participants will experience a clinical encounter with a healthcare team that has received training on evidence-based communication strategies for patients with communication disabilities, and will also complete a "patient prompt" list that elicits strategies that they prefer the healthcare team to use during their visit.
Participants will experience a clinical encounter with a healthcare team that has received training on evidence-based communication strategies for patients with communication disabilities.
|
Active Comparator: Healthcare team-directed intervention
Team education
|
Participants will experience a clinical encounter with a healthcare team that has received training on evidence-based communication strategies for patients with communication disabilities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Patient Health-Related Quality of Life
Time Frame: 1 week, 6 months
|
One week following their clinical encounter, patients will complete the PROMIS Global Health measure, which includes 10 items that measure Health-Related Quality of Life.
The measure includes items that ask the patient to rate their pain, fatigue and emotional wellbeing for the past 7 days.
We will ask these questions again 6 months after the clinical encounter.
|
1 week, 6 months
|
Patient Experience with the Clinical Visit
Time Frame: Baseline
|
Following their clinical encounter, patients will complete 2 subscales of the Patients' Perceptions of Quality of Care (PPQC) survey; Providers' Bedside Manner and Providers' work.
Both subscales include questions about the quality of communication with their provider during their appointment.
The PPQC has been demonstrated to detect differences in experience between patients with and without disabilities in the primary care setting.
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Provider Use of Communication Strategies
Time Frame: Baseline
|
Providers' use of patient-centered communication and strategies will be measured through a content analysis of video-recorded clinical encounters of a subset of patients.
The recorded video will be analyzed using the Roter Interaction Analysis System (RIAS), which is a coding system that will yield the ratio of the degree of patient-centered communication in the clinical encounter.
|
Baseline
|
Patient Self-Efficacy for Management of Chronic Conditions
Time Frame: 1 week
|
One week following the clinical encounter, patients will complete the PROMIS Global Health measure, which includes 8 items that measure Self-Efficacy for Management of Chronic Conditions.
The measure includes items that ask about patients' self-efficacy for managing medications, treatments, and symptoms.
|
1 week
|
Provider Satisfaction with Quality of Interaction
Time Frame: Baseline
|
Providers' perceptions of the communication will be measured using the Physician Satisfaction with Primary Care Office Visits survey, which has been used concurrently with the RIAS coding system to assess providers' perspectives of communication with diverse populations.
The survey includes 20 items on a Likert scale.
|
Baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Hospital Admissions
Time Frame: 6 months
|
Electronic Health Record data will identify the number of hospital admissions among participating patients.
|
6 months
|
Patient Emergency Department (ED) Use
Time Frame: 6 months
|
Electronic Health Record data will identify the frequency of ED use among participating patients.
|
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Megan A Morris, PhD, MPH, University of Colorado, Denver
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20-3148
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Communication Disabilities
-
IRCCS Centro Neurolesi "Bonino-Pulejo"Recruiting
-
IRCCS Fondazione Stella MarisFondazione Policlinico Universitario Agostino Gemelli IRCCS; Fondazione I.R... and other collaboratorsRecruitingNeurodevelopmental Cognitive, Motor and Speech-language DisabilitiesItaly
-
Weill Medical College of Cornell UniversityNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; New...CompletedCritical Illness | Communication DisabilitiesUnited States
-
Beacon Hill AcademyAnglia Ruskin University; The Music Therapy Charity LtdWithdrawnChild Development Disorders, Specific | Developmental Communication DisordersUnited Kingdom
-
Centre Hospitalier Intercommunal CreteilAssociation pour la recherche des troubles de l'apprentissage; Orthoédition; Association... and other collaboratorsCompletedDevelopmental Disability | Learning Disorders, SpecificFrance, Martinique
-
University of Notre DameRecruitingCommunication | Family Conflict | Marital ConflictUnited States
-
City, University of LondonCompletedVision Disorders | Reading DisabilitiesUnited Kingdom
-
National Cheng-Kung University HospitalCompleted
-
Manchester University NHS Foundation TrustCompleted
-
University of KansasNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedDevelopmental Disabilities | Communication DisordersUnited States
Clinical Trials on Healthcare team- + patient-directed intervention
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Denver Health and Hospital AuthorityUniversity of Colorado, Denver; National Heart, Lung, and Blood Institute (NHLBI)Completed
-
University of Southern CaliforniaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Active, not recruitingEczema | Atopic Dermatitis | Atopic Dermatitis EczemaUnited States
-
Syracuse VA Medical CenterAmerican Foundation for Suicide PreventionCompletedSuicide PreventionUnited States
-
Baylor Research InstituteCompleted
-
Centre Hospitalier Universitaire de NīmesCompletedChronic Obstructive Pulmonary Disease | Atherosclerosis | Type II DiabetesFrance
-
University of UtahNew York UniversityEnrolling by invitationCancer | Risk Reduction BehaviorUnited States
-
University of FloridaRTI International; Centers for Medicare and Medicaid Services; Econometrica,...CompletedChronic Mental Illness | Chronic Physical IllnessUnited States
-
Shepherd Center, Atlanta GAPatient-Centered Outcomes Research InstituteUnknownSpinal Cord Injury | Peer Group
-
VA Office of Research and DevelopmentCompletedSchizophrenia Spectrum & Other Psychotic DisordersUnited States